Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R M Asquith

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|March 2, 2025
Medicinal chemistry applications of the Dimroth Rearrangement to the synthesis of biologically active compoundsLuca Pozzetti, Maja M Pinhammer, Christopher R M Asquith
Nature Reviews. Drug Discovery|November 7, 2020
WNK kinases: an untapped opportunity to modulate ion transportMichael P East, Tuomo Laitinen, Christopher R M Asquith
Nature Reviews. Drug Discovery|November 2, 2019
ADCK3/COQ8A: the choice target of the UbiB protein kinase-like familyChristopher R M Asquith, Nathan H Murray, David J Pagliarini
Nature Reviews. Drug Discovery|February 18, 2026
PIP4K2C: an emerging fulcrum for multiple diseasesLuca Pozzetti, Manjari Mishra, Shirit Einav, et al.
Nature Reviews. Drug Discovery|August 2, 2019
RIOK2: straddling the kinase/ATPase lineChristopher R M Asquith, Michael P East, William J Zuercher
Bioorganic & Medicinal Chemistry Letters|May 27, 2019
Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK)Christopher R M Asquith, Daniel K Treiber, William J Zuercher
Molecules (Basel, Switzerland)|April 13, 2023
The Synthesis and Biological Applications of the 1,2,3-Dithiazole ScaffoldAndreas S Kalogirou, Hans J Oh, Christopher R M Asquith
Bioorganic & Medicinal Chemistry Letters|October 8, 2021
Identification and evaluation of 4-anilinoquin(az)olines as potent inhibitors of both dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV)Sirle Saul, Pei-Tzu Huang, Shirit Einav, et al.
Nature Reviews. Drug Discovery|October 17, 2024
TLK2: a target for cancer and viral latencyLuca Pozzetti, Michael P East, Tuomo Laitinen, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Optimization of 4-Anilinoquinolines as Dengue Virus InhibitorsPei-Tzu Huang, Sirle Saul, Shirit Einav, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|March 2, 2025
Medicinal chemistry applications of the Dimroth Rearrangement to the synthesis of biologically active compoundsLuca Pozzetti, Maja M Pinhammer, Christopher R M Asquith
Nature Reviews. Drug Discovery|November 7, 2020
WNK kinases: an untapped opportunity to modulate ion transportMichael P East, Tuomo Laitinen, Christopher R M Asquith
Nature Reviews. Drug Discovery|November 2, 2019
ADCK3/COQ8A: the choice target of the UbiB protein kinase-like familyChristopher R M Asquith, Nathan H Murray, David J Pagliarini
Nature Reviews. Drug Discovery|February 18, 2026
PIP4K2C: an emerging fulcrum for multiple diseasesLuca Pozzetti, Manjari Mishra, Shirit Einav, et al.
Nature Reviews. Drug Discovery|August 2, 2019
RIOK2: straddling the kinase/ATPase lineChristopher R M Asquith, Michael P East, William J Zuercher
Bioorganic & Medicinal Chemistry Letters|May 27, 2019
Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK)Christopher R M Asquith, Daniel K Treiber, William J Zuercher
Molecules (Basel, Switzerland)|April 13, 2023
The Synthesis and Biological Applications of the 1,2,3-Dithiazole ScaffoldAndreas S Kalogirou, Hans J Oh, Christopher R M Asquith
Bioorganic & Medicinal Chemistry Letters|October 8, 2021
Identification and evaluation of 4-anilinoquin(az)olines as potent inhibitors of both dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV)Sirle Saul, Pei-Tzu Huang, Shirit Einav, et al.
Nature Reviews. Drug Discovery|October 17, 2024
TLK2: a target for cancer and viral latencyLuca Pozzetti, Michael P East, Tuomo Laitinen, et al.
Molecules (Basel, Switzerland)|December 10, 2021
Optimization of 4-Anilinoquinolines as Dengue Virus InhibitorsPei-Tzu Huang, Sirle Saul, Shirit Einav, et al.
Pageof 6